Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2025-02-24 Sale |
2025-02-26 6:27 pm |
OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks |
21,475 | $6.87 | $147,533 | 3,520,318 (Direct) |
View |
| 2025-02-24 Sale |
2025-02-26 6:25 pm |
OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer |
3,061 | $6.87 | $21,029 | 265,998 (Direct) |
View |
| 2025-02-24 Sale |
2025-02-26 6:24 pm |
OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer |
3,009 | $6.87 | $20,672 | 210,078 (Direct) |
View |
| 2025-02-24 Sale |
2025-02-26 6:22 pm |
OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer |
1,895 | $6.84 | $12,962 | 283,485 (Direct) |
View |
| 2025-01-31 Sale |
2025-02-04 7:16 pm |
OCULAR THERAPEUTIX INC | OCUL | Notman Donald See Remarks |
17,420 | $7.8209 | $136,239 | 193,444 (Direct) |
View |
| 2024-11-25 Sale |
2024-11-27 07:52 am |
OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer |
2,948 | $9.01 | $26,561 | 269,059 (Direct) |
View |
| 2024-11-25 Sale |
2024-11-27 07:51 am |
OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer |
2,897 | $9.01 | $26,102 | 213,087 (Direct) |
View |
| 2024-11-25 Sale |
2024-11-27 07:49 am |
OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer |
1,814 | $9 | $16,326 | 174,380 (Direct) |
View |
| 2024-11-25 Sale |
2024-11-27 07:47 am |
OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks |
20,680 | $9.01 | $186,327 | 791,793 (Direct) |
View |
| 2024-08-23 Sale |
2024-08-27 5:19 pm |
OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer |
1,832 | $9.02 | $16,525 | 176,194 (Direct) |
View |
| 2024-08-23 Sale |
2024-08-27 5:17 pm |
OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks |
20,880 | $9.02 | $188,338 | 812,473 (Direct) |
View |
| 2024-05-23 Sale |
2024-05-28 5:01 pm |
OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer |
2,274 | $5.84 | $13,280 | 178,026 (Direct) |
View |
| 2024-05-23 Sale |
2024-05-28 5:00 pm |
OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks |
21,626 | $5.79 | $125,215 | 833,353 (Direct) |
View |
| 2024-02-26 Purchase |
2024-02-27 4:43 pm |
OCULAR THERAPEUTIX INC | OCUL | SUMMER ROAD LLC 10% Owner |
930,851 | $7.52 | $7,000,000 | 8,591,401 (Indirect) |
View |
| 2024-02-05 Sale |
2024-02-06 6:38 pm |
OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer |
5,910 | $4.86 | $28,723 | 243,689 (Direct) |
View |
| 2024-02-05 Sale |
2024-02-06 6:35 pm |
OCULAR THERAPEUTIX INC | OCUL | Strassburger Philip C. General Counsel |
6,029 | $4.86 | $29,301 | 336,493 (Direct) |
View |
| 2024-02-05 Sale |
2024-02-06 6:32 pm |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
6,346 | $4.86 | $30,842 | 353,054 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-02-11 Option Award |
2025-02-13 8:38 pm |
N/A N/A |
OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin See Remarks |
2,750,000 | $0 | 3,541,793 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 8:37 pm |
N/A 2035-02-10 |
OCULAR THERAPEUTIX INC | OCUL | Waheed Nadia Chief Medical Officer |
316,000 | $0 | 457,666 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 8:36 pm |
N/A 2035-02-10 |
OCULAR THERAPEUTIX INC | OCUL | Notman Donald See Remarks |
459,115 | $0 | 652,559 (Direct) |
View |
| 2025-02-11 Option Award |
2025-02-13 8:35 pm |
N/A 2035-02-10 |
OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer |
445,000 | $0 | 619,380 (Direct) |
View |
| 2024-10-07 Option Award |
2024-10-09 5:32 pm |
N/A 2034-10-06 |
OCULAR THERAPEUTIX INC | OCUL | Anderman Todd Chief Legal Officer |
395,200 | $0 | 395,200 (Direct) |
View |
| 2024-10-02 Option Award |
2024-10-04 5:21 pm |
N/A 2034-10-01 |
OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer |
300,000 | $0 | 415,984 (Direct) |
View |
| 2024-10-02 Option Award |
2024-10-04 5:20 pm |
N/A 2034-10-01 |
OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer |
300,000 | $0 | 472,007 (Direct) |
View |
Ownership |
2024-10-04 5:18 pm |
N/A N/A |
OCULAR THERAPEUTIX INC | OCUL | Kaiser Peter Chief Development Officer |
0 | $0 | 682,650 (Direct) |
View |
Ownership |
2024-10-04 5:17 pm |
N/A N/A |
OCULAR THERAPEUTIX INC | OCUL | Heier Jeffrey S. Chief Scientific Officer |
0 | $0 | 745,186 (Direct) |
View |
| 2024-08-29 Option Award |
2024-09-03 4:08 pm |
N/A 2034-08-28 |
OCULAR THERAPEUTIX INC | OCUL | Notman Donald See Remarks |
44,636 | $0 | 242,590 (Direct) |
View |
| 2024-07-24 Option Award |
2024-07-26 7:30 pm |
N/A 2034-07-23 |
OCULAR THERAPEUTIX INC | OCUL | LINDSTROM RICHARD L MD Director |
48,000 | $0 | 198,704 (Direct) |
View |
| 2024-02-27 Exercise |
2024-07-26 7:30 pm |
N/A N/A |
OCULAR THERAPEUTIX INC | OCUL | LINDSTROM RICHARD L MD Director |
30,302 | $8.8 | 198,704 (Direct) |
View |
| 2024-02-27 Exercise |
2024-07-26 7:30 pm |
N/A 2024-04-13 |
OCULAR THERAPEUTIX INC | OCUL | LINDSTROM RICHARD L MD Director |
30,302 | $0 | 198,704 (Direct) |
View |
| 2024-07-24 Option Award |
2024-07-26 6:41 pm |
N/A 2034-07-23 |
OCULAR THERAPEUTIX INC | OCUL | Hong Seung Suh Director |
48,000 | $0 | 68,933 (Direct) |
View |
| 2024-07-24 Option Award |
2024-07-26 6:40 pm |
N/A 2034-07-23 |
OCULAR THERAPEUTIX INC | OCUL | RAINES MERILEE Director |
48,000 | $0 | 68,933 (Direct) |
View |
| 2024-07-24 Option Award |
2024-07-26 6:40 pm |
N/A 2034-07-23 |
OCULAR THERAPEUTIX INC | OCUL | Williams Leslie J. Director |
48,000 | $0 | 73,433 (Direct) |
View |
| 2024-07-24 Option Award |
2024-07-26 6:39 pm |
N/A 2034-07-23 |
OCULAR THERAPEUTIX INC | OCUL | Warden Charles M Director |
48,000 | $0 | 108,464 (Direct) |
View |
| 2024-07-24 Option Award |
2024-07-26 6:38 pm |
N/A 2034-07-23 |
OCULAR THERAPEUTIX INC | OCUL | Graves Adrienne L Director |
48,000 | $0 | 72,000 (Direct) |
View |
| 2024-06-01 Option Award |
2024-06-04 5:28 pm |
N/A 2034-05-31 |
OCULAR THERAPEUTIX INC | OCUL | Waheed Nadia Chief Medical Officer |
566,666 | $0 | 566,666 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 8:07 pm |
N/A 2024-02-21 |
OCULAR THERAPEUTIX INC | OCUL | Dugel Pravin Executive Chairman |
2,137,448 | $0 | 2,137,448 (Direct) |
View |
| 2024-02-22 Option Award |
2024-02-26 8:06 pm |
N/A 2024-02-21 |
OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer |
324,850 | $0 | 424,850 (Direct) |
View |
Ownership |
2024-02-26 8:02 pm |
N/A N/A |
OCULAR THERAPEUTIX INC | OCUL | Nayak Sanjay Chief Strategy Officer |
0 | $0 | 100,000 (Direct) |
View |
| 2024-02-03 Option Award |
2024-02-06 6:38 pm |
N/A 2034-02-02 |
OCULAR THERAPEUTIX INC | OCUL | White Christopher G Chief Business Officer |
159,980 | $0 | 243,689 (Direct) |
View |
| 2024-02-03 Option Award |
2024-02-06 6:35 pm |
N/A 2034-02-02 |
OCULAR THERAPEUTIX INC | OCUL | Strassburger Philip C. General Counsel |
233,304 | $0 | 336,493 (Direct) |
View |
| 2024-02-03 Option Award |
2024-02-06 6:32 pm |
N/A 2034-02-02 |
OCULAR THERAPEUTIX INC | OCUL | Ozden Rabia Gurses Chief Medical Officer |
266,633 | $0 | 353,054 (Direct) |
View |